The US Food and Drug Administration (US FDA) has issued an establishment inspection report for the companys Aurangabad manufacturing facility. The US FDA has determined that the inspection classification of the facility is voluntary action indicated (VAI). The inspection of the said facility was conducted on March 6%u201315, 2024.
Price when posted : NSE: Rs. 1590.85
Kamal20 what is an EIR? Is it an adverse report?
Price when posted : NSE: Rs. 1581.00
The US Food and Drug Administration (US FDA) has issued an establishment inspection report for the companys Aurangabad manufacturing facility. The US FDA has determined that the inspection classification of the facility is voluntary action indicated (VAI). The inspection of the said facility was conducted on March 6%u201315, 2024.
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL